###begin article-title 0
A Novel Role for IkappaBzeta in the Regulation of IFNgamma Production
###end article-title 0
###begin p 1
Conceived and designed the experiments: RMR SS. Performed the experiments: RMR YK VBA. Analyzed the data: RMR YK SS MDW. Contributed reagents/materials/analysis tools: HW DCG MDW. Wrote the paper: RMR MDW.
###end p 1
###begin p 2
IkappaBzeta is a novel member of the IkappaB family of NFkappaB regulators, which modulates NFkappaB activity in the nucleus, rather than controlling its nuclear translocation. IkappaBzeta is specifically induced by IL-1beta and several TLR ligands and positively regulates NFkappaB-mediated transcription of genes such as IL-6 and NGAL as an NFkappaB binding co-factor. We recently reported that the IL-1 family cytokines, IL-1beta and IL-18, strongly synergize with TNFalpha for IFNgamma production in KG-1 cells, whereas the same cytokines alone have minimal effects on IFNgamma production. Given the striking similarities between the IL-1R and IL-18R signaling pathways we hypothesized that a common signaling event or gene product downstream of these receptors is responsible for the observed synergy. We investigated IkappaBzeta protein expression in KG-1 cells upon stimulation with IL-1beta, IL-18 and TNFalpha. Our results demonstrated that IL-18, as well as IL-1beta, induced moderate IkappaBzeta expression in KG-1 cells. However, TNFalpha synergized with IL-1beta and IL-18, whereas by itself it had a minimal effect on IkappaBzeta expression. NFkappaB inhibition resulted in decreased IL-1beta/IL-18/TNFalpha-stimulated IFNgamma release. Moreover, silencing of IkappaBzeta expression led to a specific decrease in IFNgamma production. Overall, our data suggests that IkappaBzeta positively regulates NFkappaB-mediated IFNgamma production in KG-1 cells.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 235 238 216 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Raices1">[1]</xref>
###xml 438 441 416 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Dunne1">[2]</xref>
###xml 442 445 420 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamamoto1">[5]</xref>
###xml 191 196 <span type="species:ncbi:9606">human</span>
We previously showed that the Interleukin-1 (IL-1) family members, IL-1beta and IL-18, synergize with tumor necrosis factor-alpha (TNFalpha) for interferon-gamma (IFNgamma) production in the human acute myeloid leukemic KG-1 cell line [1]. IL-1beta and IL-18 signal via the Interleukin-1 receptor (IL-1R) and IL-18R, respectively, both of which belong to the IL-1R family and the interleukin-1R/Toll-like receptor (IL-1R/TLR) superfamily [2]-[5]. Members of the IL-1R/TLR family share a cytoplasmic domain known as the Toll/interleukin-1 receptor (TIR) domain and recruit similar adaptor proteins, such as MyD88. Due to these and other similarities, the signaling pathways downstream of IL-1Rs and TLRs lead to similar outcomes, such as the activation of NFkappaB and MAPKs.
###end p 4
###begin p 5
###xml 216 219 205 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Bradley1">[6]</xref>
###xml 220 223 209 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kracht1">[8]</xref>
###xml 460 463 442 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Cowland1">[9]</xref>
###xml 494 498 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Liu1">[10]</xref>
###xml 499 503 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-TsutsumiIshii1">[14]</xref>
###xml 552 556 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-MacNaul1">[15]</xref>
###xml 566 570 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Ng1">[16]</xref>
###xml 571 575 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Elias1">[18]</xref>
###xml 723 727 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Katz1">[17]</xref>
###xml 954 957 900 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Dunne1">[2]</xref>
###xml 958 961 904 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamamoto1">[5]</xref>
###xml 963 967 909 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamazaki1">[19]</xref>
###xml 968 972 914 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Cowland2">[24]</xref>
###xml 465 470 <span type="species:ncbi:9606">human</span>
Although the IL-1beta and TNFalpha receptors (IL-1R and TNFR) belong to different families, their signaling pathways utilize similar adaptor molecules, such as TRAFs, and lead to the activation of NFkappaB and MAPKs [6]-[8]. Therefore, many of the genes induced by IL-1beta and TNFalpha overlap and the two cytokines lead to similar biological effects. However, induction of certain genes, such as neutrophil geletinase-associated lipocalin (NGAL)/lipocalin-2 [9], human beta-defensin 2 (hBD2) [10]-[14], extracellular matrix metalloprotease 3 (MMP-3) [15] and IL-6 [16]-[18], is specific for IL-1beta. In the same way, expression of other genes, such as complement factor H, is specific for the TNFalpha signaling pathway [17]. Moreover, expression of the novel member of the IkappaB family of NFkappaB regulators, IkappaBzeta, has been shown to be specific to the IL-1R/TLR pathway (e.g. upon IL-1alpha/beta, LPS stimulation), not the TNFalpha pathway [2]-[5], [19]-[24].
###end p 5
###begin p 6
###xml 93 97 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamazaki1">[19]</xref>
###xml 98 102 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Shiina1">[31]</xref>
###xml 301 305 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamamoto2">[21]</xref>
###xml 307 311 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Cowland2">[24]</xref>
###xml 313 317 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kitamura1">[26]</xref>
###xml 319 323 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Muta2">[30]</xref>
###xml 325 329 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kayama1">[32]</xref>
###xml 330 334 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kao1">[36]</xref>
###xml 385 389 364 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Matsuo1">[33]</xref>
###xml 537 541 501 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamazaki1">[19]</xref>
###xml 543 547 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamamoto2">[21]</xref>
###xml 549 553 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Cowland2">[24]</xref>
###xml 555 559 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kitamura1">[26]</xref>
###xml 561 565 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Muta1">[29]</xref>
###xml 567 571 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Muta2">[30]</xref>
###xml 573 577 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kayama1">[32]</xref>
###xml 578 582 542 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Motoyama1">[34]</xref>
###xml 584 588 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Totzke1">[37]</xref>
###xml 815 819 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamazaki1">[19]</xref>
###xml 821 825 755 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Haruta1">[23]</xref>
###xml 827 831 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kitamura1">[26]</xref>
###xml 833 837 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Muta1">[29]</xref>
###xml 915 919 845 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Bours1">[38]</xref>
###xml 920 924 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Zhang1">[50]</xref>
IkappaBzeta expression is immediately induced upon stimulation with TLR ligands and IL-1beta [19]-[31]. Moreover, IkappaBzeta is essential for NFkappaB-mediated induction of genes encoding for proteins such as IL-6, NGAL, hBD2, IL-12 p40, and granulocyte-macrophage colony-stimulating factor (GM-CSF) [21], [24], [26], [30], [32]-[36], and for the suppression of E-selectin expression [33]. IkappaBzeta has been shown to positively and negatively regulate NFkappaB-mediated transcription by binding to the p50 subunit of NFkappaB dimers [19], [21], [24], [26], [29], [30], [32]-[34], [37]. This is in contrast to other IkappaB members, such as IkappaBalpha/beta, which are mainly found in the cytosol and modulate NFkappaB nuclear translocation. IkappaBzeta is most homologous to the nuclear IkappaB protein, Bcl-3 [19], [23], [26], [29], which also regulates NFkappaB-mediated transcription as a binding co-factor [38]-[50].
###end p 6
###begin p 7
###xml 112 115 101 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Raices1">[1]</xref>
We recently showed that both, IL-1beta and IL-18, synergize with TNFalpha for IFNgamma production in KG-1 cells [1]. Given the similarities between the IL-1R and IL-18R signaling pathways, we hypothesized that a common event downstream of these two receptors is crucial for the observed synergy between IL-1beta/IL-18 and TNFalpha for IFNgamma production. Even though both, the IL-1R and IL-18R, belong to the IL-1R/TLR superfamily, and IkappaBzeta is specifically induced upon stimulation with several IL-1R/TLR ligands, IkappaBzeta expression has not been investigated in response to IL-18 stimulation. Therefore, we analyzed IkappaBzeta expression in KG-1 cells upon IL-18 and IL-1beta stimulation, and the role of IkappaBzeta in IFNgamma production in response to combined IL-1beta/IL-18 and TNFalpha stimulation. Our results indicate that stimulation with IL-1beta and/or IL-18 results in moderate levels of IkappaBzeta production, while TNFalpha has no effect. However, when combined with IL-1beta or IL-18, TNFalpha strongly enhances IkappaBzeta protein expression. Moreover, NFkappaB inhibition, as well as silencing of IkappaBzeta expression, resulted in decreased IL-1beta/IL-18/TNFalpha-induced IFNgamma production. Furthermore, IL-1R and IL-18R expression analysis indicated that the observed synergy may take place at the receptor level in the case of IL-18 and TNFalpha, but not IL-1beta and TNFalpha combined stimulation. In summary, our findings indicate that stimulation with the IL-1 cytokines, IL-1beta and IL-18, in combination with TNFalpha results in synergistic KG-1 IFNgamma production in an IkappaBzeta/NFkappaB dependent manner.
###end p 7
###begin title 8
Methods
###end title 8
###begin title 9
Reagents
###end title 9
###begin p 10
###xml 9 25 9 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 9 25 <span type="species:ncbi:562">Escherichia coli</span>
###xml 27 34 <span type="species:ncbi:562">E. coli</span>
###xml 183 188 <span type="species:ncbi:9606">human</span>
###xml 330 335 <span type="species:ncbi:9606">human</span>
###xml 1050 1056 <span type="species:ncbi:9986">Rabbit</span>
Purified Escherichia coli (E. coli) LPS (serotype 0111:B4) was obtained from Axxora (San Diego, CA) and cell culture tested ATP disodium salt from Sigma-Aldrich (St. Louis, MO). Anti-human IL-8 ELISA capture monoclonal Ab (clone 6217), IL-18 monoclonal Ab (clone 159-12B), IL-18 receptor (IL-18R) monoclonal Ab (clone 70625), and human rIL-1beta, rIL-18 and rIL-8 were purchased from R&D Systems (Minneapolis, MN). An IkappaBalpha polyclonal Ab was obtained from Upstate (Billerica, Massachusetts), actin monoclonal Ab (clone C4) from MP Biomedicals (Solon, OH), p50 monoclonal (clone E-10) Ab and p65 polyclonal Ab from Santa Cruz (Santa Cruz, CA), lamin B1 polyclonal Ab from Abcam (Cambridge, MA), TNFalpha capture monoclonal Ab (clone 2C8) from Advanced Immunochemical (Long Beach, CA), IL-8 ELISA detection polyclonal Ab from Endogen (Rockford, IL), rTNFalpha from Knoll Pharmaceuticals (Whippany, NJ), Interleukin-1 receptor antagonist (IL-1ra) from Amgen (Thousand Oaks, CA), and IFNgamma and IL-6 ELISA kits from eBioscience (San Diego, CA). Rabbit anti-serum against IkappaBzeta and IL-1beta and pre-immune serum were developed in our laboratory. The NFkappaB inhibitor, JSH23, was purchased from Calbiochem (San Diego, CA). A mixture of three different small interfering RNA (siRNA) oligonucleotides against IkappaBzeta and three different scrambled siRNA oligonucleotides were purchased from Dharmacon RNA Technologies (Lafayette, CO). The cell line nucleofector kit R was purchased from Amaxa (Gaithersburg, MD).
###end p 10
###begin title 11
Cell Culture
###end title 11
###begin p 12
###xml 267 268 261 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 586 587 580 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 604 605 598 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 829 830 817 818 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1050 1051 1038 1039 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 316 321 <span type="species:ncbi:9606">human</span>
###xml 872 879 <span type="species:ncbi:562">E. coli</span>
KG-1 cells (American Type Culture Collection, ATCC; Manassas, VA) were maintained in RPMI 1640 (Mediatech Inc, Herndon, VA), supplemented with 20% FBS (Atlas Biologicals, Fort Collins, CO) and 1% penicillin/streptomycin in a 37degreesC humidified incubator with 5% CO2. Peripheral blood monocytes were isolated from human blood by density gradient centrifugation using lymphocyte separation media (Cell Grow, Media Tech, Herndon, VA) followed by CD14 positive selection (Miltenyi Biotec, Auburn, CA), which yields>95% purity as determined by FACS. Isolated monocytes were cultured at 106/ml or at 12.5x106/ml in RPMI 1640 (Cambrex, East Rutherford, New Jersey), supplemented with 5% FBS (<0.0005 EU/ml) (HyClone, Logan, UT) and 1% penicillin/streptomycin (GIBCO, Grand Island, NY), in a 37degreesC humidified incubator with 5% CO2. Monocytes were stimulated, or not, with E. coli LPS (10 ng/ml) for 4 h and ATP (5 mM) for the last 15 min of LPS stimulation, or with LPS or ATP alone. The supernatants (conditioned media) from monocytes cultured at 106/ml were harvested by centrifugation (5 min; 3 600 rpm) and used to stimulate KG-1 cells.
###end p 12
###begin p 13
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
KG-1 cells were plated at a final cell density of 106/ml and incubated with test samples (monocyte conditioned media, 1/3 of the final volume) or recombinant proteins (10 ng/ml each). In selected experiments, neutralizing agents for IL-1beta (IL-1beta Ab - clone 2805, IL-1ra), IL-18 (IL-18 Ab - clone 125-2H, or IL-18R Ab - clone 70625), and/or TNFalpha (TNFalpha Ab - clone 2C8) were used at the indicated concentrations to neutralize the activities of rIL-18, rIL-1beta and/or rTNFalpha, or the same endogenous cytokines present in the monocyte conditioned media, prior to incubation with KG-1 cells. Alternatively, the neutralizing agents, IL-1ra and IL-18R Ab, were used to neutralize IL-18 or IL-1 receptors prior to addition of rIL-18, rIL-1beta, or monocyte conditioned media, to the KG-1 cells. KG-1 supernatants and cells were harvested at various time points for subsequent ELISA and Western blot analysis. In selected experiments, cells were treated with the NFkappaB inhibitor, JSH-23 (30 microM) (an NFkappaB nuclear translocation inhibitor), in combination with rIL-1beta, rIL-18 and rTNFalpha for 24 h. KG-1 cells were harvested at 12 h for subsequent nuclear extraction and Western blot analysis. KG-1 supernatants were harvested at 24 h for IL-6 and IFNgamma ELISA.
###end p 13
###begin title 14
Western blotting
###end title 14
###begin p 15
###xml 703 712 <span type="species:ncbi:3570">Carnation</span>
KG-1 cells were lysed in a 60 mM Tris-HCl (pH 6.8), 2% SDS buffer. Total cell extracts were sonicated and spun (5 min; 10 000 rpm, R.T.) to remove cell debris. KG-1 nuclear/cytosolic extracts were also analyzed by Western blotting. Protein concentration in total, nuclear or cytosolic extracts was estimated using the Bio-Rad Dc protein Lowry assay (Bio-Rad). Samples were boiled in Laemmli's buffer for 5 min or heated at 70degreesC for 10 min in NuPAGE Sample Reducing Agent (Invitrogen). 10-40 microg of total protein were loaded per well on pre-cast 10% Tris-Glycine or 7% Tris-Acetate SDS-PAGE gels and transferred to a PVDF or nitrocellulose membrane. Membranes were blocked with 10% nonfat milk (Carnation, Nestle) in 25 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 0.05% Tween for 1 h at R.T. The membranes were probed with the indicated primary Abs, followed by peroxidase-conjugated secondary antibodies. Protein bands were visualized by chemiluminescence (GE Healthcare).
###end p 15
###begin title 16
ELISA
###end title 16
###begin p 17
Sandwich ELISAs were used to measure cytokine release in the supernatants of KG-1 cells.
###end p 17
###begin title 18
Flow Cytometry
###end title 18
###begin p 19
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 201 202 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 231 232 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 543 544 514 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 661 662 628 629 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 189 194 <span type="species:ncbi:9606">human</span>
###xml 651 657 <span type="species:ncbi:10090">murine</span>
###xml 687 691 <span type="species:ncbi:9925">goat</span>
KG-1 cells (106/ml) were stimulated, or not, with the indicated combinations of rIL-1beta, rIL-18 and rTNFalpha (10 ng/ml each) for 24 h. Cells were Fc-blocked by treating with 1 microg of human IgG/105 for 15 min at R.T. Cells (105/25 microl*reaction) were transferred to a 5 ml tube. Phycoerythrin (PE)-conjugated anti-IL-18Ralpha or fluorescein (FITC)-conjugated anti-IL-1R1 reagent (10 microl of each per reaction) were added to the cells. Cells were incubated for 30 min at 4degreesC, washed twice with 1xPBS and re-suspended in 1xPBS (105/200 microl) for flow cytometric analysis. As controls, cells were also treated with phycoerythrin-labeled murine IgG1 and fluorescein-labeled goat IgG.
###end p 19
###begin title 20
Nuclear/Cytosolic extraction
###end title 20
###begin p 21
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 396 397 385 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1057 1058 1022 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
KG-1 cells (106/ml) were stimulated, or not, with rIL-1beta, rIL-18, rTNFalpha (10 ng/ml each), or a combination of this cytokines for the indicated time points. Cells were washed twice in 1xPBS and gently re-suspended in cold Buffer A (10 mM HEPES, pH 7.9; 10 mM KCl; 0.1 mM EDTA; 0.1 mM EGTA; 1 mM dithiothreitol [DTT]; 1xComplete Mini protease inhibitor cocktail, Roche) at 400 microl/0.5-1x106 cells. Cells were allowed to swell for 15 min. 10% Nonidet NP-40 was added to the solution (25 microl per 400 microl). Samples were vortexed for 10 sec and centrifuged for 30 sec (4degreesC, 13 200 rpm). Supernatants containing cytosolic contents were transferred to fresh tubes containing an equal volume of Buffer B (10 mM Tris-HCl, pH 7.5; 7 M urea; 1% SDS; 0.3 M NaAc; 20 mM EDTA) and stored immediately at -20degreesC. The pellets containing the nuclear contents were re-suspended in cold Buffer C (20 mM HEPES, pH 7.9; 0.4 M NaCl; 1 mM EDTA; 1 mM EGTA; 1 mM dithiothreitol (DTT); 1xComplete Mini protease inhibitor cocktail, Roche) at 50 microl/0.5-1x106 cells. The samples were vigorously shook for 15 min at 4degreesC on a shaking platform and then centrifuged for 5 min (4degreesC, 13 200 rpm). The supernatants with the nuclear contents were stored at -20degreesC. Nuclear and cytosolic extracts were subsequently analyzed for protein concentration using the Bio-Rad Dc protein Lowry assay (Bio-Rad). Nuclear and cytosolic extracts were then prepared for Western blot analysis.
###end p 21
###begin title 22
Small interfering RNA
###end title 22
###begin p 23
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 331 332 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
KG-1 cells (2x106/ml) were nucleofected following the protocol for KG-1 cell nucleofection provided with the cell line nucleofector kit R from Amaxa (Gaithersburg, MD) with a mixture of 3 different small interfering RNA (siRNA) oligonucleotides against IkappaBzeta or 3 different scrambled siRNA oligonucleotides (3 microg per 2x106 cells). After 2 h, cells were stimulated with a combination of rIL-1beta, rIL-18 and rTNFalpha (10 ng/ml each). Cells and supernatants were harvested at 24 h for subsequent RNA and protein analysis (qPCR and Western blot, respectively).
###end p 23
###begin title 24
Quantitative PCR (qPCR)
###end title 24
###begin p 25
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
KG-1 cells (106/ml) were lysed in TRIzol reagent (Invitrogen Life Technologies) and mRNA was extracted and converted to cDNA using the Thermoscript RT-PCR system (Invitrogen Life Technologies). qPCR was performed using specific primers for IFNgamma, IL-6 and IL-8. Values were normalized to two house-keeping genes, CAP-1 and GAPDH.
###end p 25
###begin title 26
Statistical analysis
###end title 26
###begin p 27
###xml 111 112 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Data are presented mean+/-S.E.M. from>/=3 independent experiments. Comparisons were done by paired t-test with p<0.05 defined as statistically significant.
###end p 27
###begin title 28
Results
###end title 28
###begin title 29
IL-1beta and IL-18, but not TNFalpha, induce IkappaBzeta protein expression in KG-1 cells
###end title 29
###begin p 30
###xml 123 126 115 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Raices1">[1]</xref>
###xml 195 198 187 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Dunne1">[2]</xref>
###xml 326 330 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamazaki1">[19]</xref>
###xml 331 335 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Shiina1">[31]</xref>
###xml 745 748 687 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Raices1">[1]</xref>
We have recently demonstrated that IL-1R and IL-18R agonists synergize with TNFalpha for IFNgamma production in KG-1 cells [1]. The IL-1R, IL-18R and TLRs all belong to the IL-1R/TLR superfamily [2]. Because expression of the IkappaB protein family member, IkappaBzeta, is known to be induced downstream of the IL-1R and TLRs [19]-[31], we chose to evaluate its potential role in IFNgamma production in response to IL-1beta/IL-18 and TNFalpha combined stimulation. We analyzed induction of IkappaBzeta protein expression in response to IL-1beta and IL-18, with the idea that IkappaBzeta may be the common factor downstream of the IL-1R and IL-18R, responsible for the observed synergy between IL-1beta/IL-18 and TNFalpha for IFNgamma production [1].
###end p 30
###begin p 31
###xml 363 372 335 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006776-g001">Fig. 1A&#8211;C</xref>
###xml 531 538 488 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 613 620 558 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006776-g001">Fig. 1C</xref>
In this context, KG-1 cells were stimulated with rIL-1beta, rIL-18 and rTNFalpha for various time points, with and without co-addition of IL-1ra or IL-18 Ab. Total cell extracts were analyzed for IkappaBzeta protein expression by Western blotting. Results indicated that both rIL-1beta and rIL-18, but not rTNFalpha, induced IkappaBzeta expression in KG-1 cells (Fig. 1A-C). The lack of rTNFalpha-mediated IkappaBzeta expression was not due to lack of biological activity of rTNFalpha, as judged by the modulation (degradation and de novo protein synthesis) of IkappaBalpha expression upon rTNFalpha stimulation (Fig. 1C). The finding that IL-1beta, as well as IL-18, both induce IkappaBzeta protein expression supports the hypothesis that IkappaBzeta may be the common factor downstream of the IL-1R and IL-18R that allows for synergy between IL-1 cytokines (IL-1beta and IL-18) and TNFalpha for IFNgamma production in KG-1 cells.
###end p 31
###begin title 32
IkappaBzeta protein expression in KG-1 cells in response to IL-1beta, IL-18 and TNFalpha stimulation.
###end title 32
###begin p 33
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
KG-1 cells (106/ml) were stimulated with rIL-1beta (A), rIL-18 (B), or rTNFalpha (C) (10 ng/ml each) for the indicated time points. At selected time points, the cells were incubated with rIL-1beta and rIL-18 in the presence of IL-1ra (100 microg/ml) or IL-18 Ab (2 microg/ml), respectively. Protein-matched total cell extracts were analyzed by Western blotting using anti-serum against IkappaBzeta, IkBalpha Ab and actin Ab. Results are representative of at least 3 separate experiments.
###end p 33
###begin title 34
TNFalpha enhances IL-1beta/IL-18-mediated IkappaBzeta expression
###end title 34
###begin p 35
###xml 73 80 62 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006776-g001">Fig. 1C</xref>
###xml 82 86 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamazaki1">[19]</xref>
###xml 87 91 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamamoto2">[21]</xref>
###xml 93 97 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Cowland2">[24]</xref>
###xml 210 214 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamazaki2">[20]</xref>
Stimulation with TNFalpha alone does not lead to IkappaBzeta expression (Fig. 1C) [19]-[21], [24]. However, TNFalpha has been shown to induce IkappaBzeta transcription to a greater extent than IL-1beta and LPS [20]. In contrast, upon actinomycin D treatment, the half-life of ectopically expressed IkappaBzeta mRNA was prolonged with IL-1beta and LPS, but unaffected by TNFalpha. Therefore, even though TNFalpha has strong IkappaBzeta transcriptional activity, IL-1/LPS may provide additional mRNA stabilization (absent with solo TNFalpha stimulation) leading to subsequent protein expression. Based on this information, we hypothesized that TNFalpha may enhance IL-1beta/IL-18-mediated IkappaBzeta protein expression by providing strong transcriptional activation, even though by itself it does not lead to IkappaBzeta protein expression.
###end p 35
###begin p 36
###xml 344 350 316 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006776-g002">Fig. 2</xref>
###xml 695 701 642 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006776-g003">Fig. 3</xref>
###xml 1027 1040 940 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006776-g003">Fig. 3B and C</xref>
###xml 1568 1571 1435 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Raices1">[1]</xref>
To test this hypothesis, KG-1 cells were stimulated with rTNFalpha alone and in combination with rIL-1beta, rIL-18, or both, for 8 and 24 h. Total cell extracts were analyzed for IkappaBzeta protein expression by Western blotting. Recombinant TNFalpha enhanced rIL-1beta- and rIL-18-mediated IkappaBzeta protein expression at both time points (Fig. 2). We then analyzed the kinetics of KG-1 IkappaBzeta protein expression in response to different combinations of rIL-1beta, rIL-18 and rTNFalpha, with and without co-addition of IL-1ra, IL-18R Ab, TNFalpha Ab, or different combinations of these neutralizing agents. Interestingly, IkappaBzeta protein expression followed an oscillating pattern (Fig. 3), which is typical of IkappaB proteins, such as IkappaBalpha. Moreover, it was evident that the observed induction of IkappaBzeta protein upon stimulation with rTNFalpha combined with rIL-1beta, rIL-18, or both, was in part due to rTNFalpha, since the induction was only partially suppressed with a TNFalpha neutralizing Ab (Fig. 3B and C). The remaining IkappaBzeta protein expression after TNFalpha neutralization was likely due to IL-1beta and/or IL-18. As expected, neutralization with IL-1ra or IL-18R Ab, resulted in complete inhibition of IkappaBzeta expression, indicating that TNFalpha by itself has no IkappaBzeta inducing activity. Interestingly, rIL-1beta, rIL-18 or the combination of these cytokines (at a dose of 10 ng/ml) results in minimal amounts of IFNgamma production by KG-1 cells, despite their ability to induce IkappaBzeta protein expression [1]. Therefore, the levels of IL-1beta/IL-18-induced IkappaBzeta protein may either not be sufficient for significant IFNgamma production (in the absence of TNFalpha stimulation), or may require an additional TNFalpha-induced factor for activation of the IFNgamma promoter.
###end p 36
###begin title 37
TNFalpha enhances IL-1beta/IL-18-induced IkappaBzeta protein expression in KG-1 cells.
###end title 37
###begin p 38
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
KG-1 cells (106/ml) were stimulated with rIL-1beta, rIL-18, rTNFalpha (10 ng/ml each), or different combinations of these cytokines for 8 and 24 h. Protein-matched total cell extracts were analyzed by Western blotting using anti-serum against IkappaBzeta and actin Ab.
###end p 38
###begin title 39
The synergistic effect of TNFalpha and IL-1beta/IL-18 on IkappaBzeta protein expression is partially suppressed with a TNFalpha-specific Ab, but completely blocked with IL-1beta and/or IL-18 neutralization.
###end title 39
###begin p 40
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
KG-1 cells (106/ml) were stimulated with rIL-1beta, rIL-18, rTNFalpha (10 ng/ml each) (A), or the indicated combinations of these cytokines (B and C) for the indicated time points. At selected time points, the cells were incubated with the recombinant proteins in the presence of IL-1ra (100 microg/ml), IL-18R Ab (10 microg/ml), TNFalpha Ab (10 microg/ml), or different combinations of these neutralizing agents. Protein-matched total cell extracts were analyzed by Western blotting using anti-serum against IkappaBzeta and actin Ab. Results are representative of at least 3 separate experiments.
###end p 40
###begin title 41
The conditioned media from LPS/ATP-stimulated monocytes induces IkappaBzeta expression in an IL-1beta-dependent, but IL-18-independent manner
###end title 41
###begin p 42
###xml 228 231 217 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Raices1">[1]</xref>
###xml 638 644 606 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006776-g004">Fig. 4</xref>
###xml 840 843 804 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Raices1">[1]</xref>
###xml 1052 1055 1012 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Raices1">[1]</xref>
We have recently shown that the conditioned media from LPS/ATP-treated monocytes induces IFNgamma release by KG-1 cells and that this induction is due to the synergistic effect of IL-1beta and TNFalpha, and independent of IL-18 [1]. Herein, we incubated KG-1 cells with conditioned media from LPS/ATP-stimulated monocytes for various time points, with and without co-addition of IL-1ra, IL-18R Ab, TNFalpha Ab, or different combinations of these neutralizing agents, and analyzed IkappaBzeta protein expression. The monocyte conditioned media induced IkappaBzeta protein expression in an IL-1beta-dependent, but IL-18-independent manner (Fig. 4). This finding correlates with our previous observation that endogenous IL-18 present in the conditioned media from LPS/ATP-stimulated monocytes does not induce IFNgamma production by KG-1 cells [1]. The lack of IL-18 IFNgamma inducing activity in the supernatants of LPS/ATP-stimulated monocytes may be due to low levels of IL-18 being released or to IL-18 being bound to its biological inhibitor, IL-18BP [1].
###end p 42
###begin title 43
The conditioned media from LPS/ATP-stimulated monocytes induces IkappaBzeta expression in an IL-1beta/TNFalpha-dependent, but IL-18-independent manner.
###end title 43
###begin p 44
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 76 77 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
KG-1 cells (106/ml) were incubated with conditioned media from monocytes (106/ml) that were stimulated with LPS (10 ng/ml, 4 h) and ATP (5 mM, last 15 min) for the indicated time points. For selected time points, the cells were incubated with the conditioned media in the presence of IL-1ra (100 microg/ml), IL-18R Ab (10 microg/ml), TNFalpha Ab (10 microg/ml), or different combinations of these neutralizing agents. Protein-matched total cell extracts were analyzed by Western blotting using anti-serum against IkappaBzeta and actin Ab. Results are representative of 3 separate experiments.
###end p 44
###begin title 45
TNFalpha upregulates IL-18R, not IL-1R expression
###end title 45
###begin p 46
###xml 77 81 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Bufler1">[51]</xref>
###xml 82 86 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Xiang1">[57]</xref>
###xml 496 502 463 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006776-g005">Fig. 5</xref>
###xml 899 902 832 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Raices1">[1]</xref>
TNFalpha has been shown to upregulate expression of the IL-18R in KG-1 cells [51]-[57]. Therefore, TNFalpha may synergize with IL-1beta in a similar manner for IkappaBzeta and IFNgamma production - by upregulating surface expression of the IL-1R. In order to explore this possibility, KG-1 cells were treated with the indicated combinations of rIL-1beta, rIL-18 and rTNFalpha for 24 h. TNFalpha treatment resulted in upregulation of IL-18R, not IL-1R expression, as determined by flow cytometry (Fig. 5). Therefore, a signaling event(s) downstream of the IL-1R and IL-18R, rather that TNFalpha-mediated receptor upregulation, is likely to be crucial for the observed synergy between IL-1 cytokines and TNFalpha for IkappaBzeta and IFNgamma production. Moreover, the greater IFNgamma production in response to rIL-18 in combination with rTNFalpha, compared to rIL-1beta in combination with rTNFalpha [1], may be explained by additional TNFalpha-mediated upregulation of the IL-18R.
###end p 46
###begin title 47
Effect of TNFalpha treatment on KG-1 IL-18R and IL-1R surface expression.
###end title 47
###begin p 48
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
KG-1 cells (106/ml) were incubated with the indicated combinations of rIL-1beta, rIL-18, rTNFalpha (10 ng/ml each) for 24 h. Cells were stained with IL-18R-PE and IL-1R-FITC followed by flow cytometry analysis. Results are representative of 3 separate experiments.
###end p 48
###begin title 49
IkappaBzeta protein localizes to the nucleus
###end title 49
###begin p 50
###xml 81 85 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamazaki1">[19]</xref>
###xml 87 91 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Haruta1">[23]</xref>
###xml 93 97 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kitamura1">[26]</xref>
###xml 99 103 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kitamura3">[28]</xref>
###xml 105 109 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Motoyama1">[34]</xref>
###xml 263 267 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kitamura3">[28]</xref>
###xml 620 626 585 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006776-g006">Fig. 6</xref>
IkappaBzeta protein has been shown to localize to the nucleus in most cell types [19], [23], [26], [28], [34]. However, IkappaBzeta has also been shown to localize to the cytoplasm in B cell rich regions of immune organs, such as lymphoid follicles in the spleen [28]. In order to confirm the cellular localization of IkappaBzeta protein in the KG-1 cell line, cells were stimulated with rIL-1beta, rIL-18, rTNFalpha and different combinations of these cytokines for 8 h and harvested for cytosol and nuclear extraction. Results demonstrate that IkappaBzeta protein localizes predominantly to the nucleus of KG-1 cells (Fig. 6), consistent with its role as a co-factor for NFkappaB-mediated transcription.
###end p 50
###begin title 51
IkappaBzeta mainly localizes to the nucleus.
###end title 51
###begin p 52
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
KG-1 cells (106/ml) were stimulated with rIL-1beta, rIL-18, rTNFalpha (10 ng/ml each), or different combinations of these cytokines for 8 h. Cells were harvested for subsequent cytosol and nuclear extraction. Protein-matched nuclear and cytosolic extracts were then analyzed by Western blotting with anti-serum against IkappaBzeta, laminB1 Ab (nuclear marker) and IL-1beta Ab (cytosolic marker). Results are representative of 3 separate experiments.
###end p 52
###begin title 53
NFkappaB inhibition leads to decreased IFNgamma and IL-6 release
###end title 53
###begin p 54
###xml 667 673 614 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006776-g007">Fig. 7</xref>
IkappaBzeta has been shown to act as an NFkappaB binding co-factor by associating with the p50 NFkappaB subunit. Therefore, we decided to test whether IFNgamma release in KG-1 cells in response to IL-1beta, IL-18 and TNFalpha combined stimulation is NFkappaB dependent. KG-1 cells were incubated with an inhibitor of NFkappaB nuclear translocation followed by IL-1beta, IL-18 and TNFalpha combined stimulation. Western blot analysis with nuclear extracts indicated a reduction in p50 and p65 nuclear localization, indicative of a decrease in NFkappaB activity (data not shown). Moreover, IL-6 and IFNgamma release were significantly reduced with NFkappaB inhibition (Fig. 7). Therefore, IkappaBzeta may regulate IFNgamma release in KG-1 cells in response to IL-1beta, IL-18 and TNFalpha combined stimulation by acting as a co-factor for NFkappaB-mediated transcription.
###end p 54
###begin title 55
NFkappaB inhibition results in decreased IFNgamma and IL-6 release.
###end title 55
###begin p 56
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 322 323 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 334 335 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
KG-1 cells (106/ml) were incubated with the NFkappaB inhibitor, JSH23 (30 microM), and subsequently stimulated with a combination of rIL-1beta, rIL-18 and rTNFalpha (10 ng/ml each). Supernatants were harvested after 24 h and analyzed for cytokine release by IL-6 and IFNgamma ELISAs. Results are shown as mean+/-S.E.M. *, p<0.05; **, p<0.005 (n = 3).
###end p 56
###begin title 57
Silencing of IkappaBzeta suppresses IFNgamma and IL-6, not IL-8 production
###end title 57
###begin p 58
###xml 169 173 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Matsuo1">[33]</xref>
###xml 237 241 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamamoto2">[21]</xref>
###xml 243 247 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Cowland2">[24]</xref>
###xml 249 253 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kitamura1">[26]</xref>
###xml 255 259 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kayama1">[32]</xref>
###xml 260 264 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Trinh1">[35]</xref>
IkappaBzeta has been shown to either negatively or positively regulate NFkappaB activity depending upon the context. Genes, such as E-selectin, are negatively regulated [33], whereas genes such as IL-6 and NGAL, are positively regulated [21], [24], [26], [32]-[35]. Because IL-1beta/IL-18 or TNFalpha blockade inhibits both IkappaBzeta protein expression and IFNgamma production in KG-1 cells, we hypothesized that IkappaBzeta positively regulates IFNgamma production.
###end p 58
###begin p 59
###xml 407 413 379 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006776-g008">Fig. 8</xref>
###xml 632 638 582 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006776-g009">Fig. 9</xref>
###xml 783 787 726 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamamoto2">[21]</xref>
###xml 789 793 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kitamura1">[26]</xref>
###xml 795 799 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kayama1">[32]</xref>
###xml 801 805 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Motoyama1">[34]</xref>
###xml 807 811 750 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Trinh1">[35]</xref>
###xml 935 939 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Cowland2">[24]</xref>
###xml 941 945 877 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Matsuo1">[33]</xref>
###xml 1099 1105 1024 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006776-g009">Fig. 9</xref>
In order to test this hypothesis, KG-1 cells were nucleofected with a mixture of 3 different small interfering RNA (siRNA) oligonucleotides against IkappaBzeta or 3 different scrambled siRNA oligonucleotides. Cells were then stimulated with a combination of rIL-1beta, rIL-18 and rTNFalpha. Western blot analysis indicated a reduction in IkappaBzeta protein expression with anti-IkappaBzeta siRNA delivery (Fig. 8). In order to determine the effect of IkappaBzeta silencing on IFNgamma protein production, we measured IFNgamma mRNA levels and protein release in KG-1 cells upon rIL-1beta, rIL-18 and rTNFalpha combined stimulation (Fig. 9). As a positive control, we measured IL-6 mRNA and protein release since this cytokine has been shown to be positively regulated by IkappaBzeta [21], [26], [32], [34], [35]. As a negative control, we measured IL-8 mRNA and protein levels, which have been shown not to be regulated by IkappaBzeta [24], [33]. Results indicated that the mRNA and protein levels of IFNgamma and IL-6, but not IL-8, were significantly reduced with anti-IkappaBzeta siRNA delivery (Fig. 9). These results implicate a role for IkappaBzeta as a positive regulator of IFNgamma production.
###end p 59
###begin title 60
Silencing of IkappaBzeta expression.
###end title 60
###begin p 61
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
KG-1 cells (2x106/ml) were nucleofected with a mixture of 3 different small interfering RNA (siRNA) oligonucleotides against IkappaBzeta or 3 different scrambled siRNA oligonucleotides. After 2 h, cells were stimulated with a combination of rIL-1beta, rIL-18 and rTNFalpha (10 ng/ml each) for the indicated time points. Protein-matched total cell extracts were analyzed by Western blotting using anti-serum against IkappaBzeta and actin Ab. Results are representative of 5 separate experiments.
###end p 61
###begin title 62
Silencing of IkappaBzeta expression suppresses IFNgamma and IL-6, not IL-8, mRNA and protein production.
###end title 62
###begin p 63
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 627 628 603 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 638 639 614 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
KG-1 cells (2x106/ml) were nucleofected with a mixture of 3 different small interfering RNA (siRNA) oligonucleotides against IkappaBzeta or 3 different scrambled siRNA oligonucleotides. After 2 h, cells were stimulated with a combination of rIL-1beta, rIL-18 and rTNFalpha (10 ng/ml each) for 24 h. Cells were lysed for mRNA extraction. Messenger RNA (mRNA) was converted to cDNA, followed by quantitative PCR (qPCR) using primers specific for IFNgamma (A), IL-6 (B) and IL-8 (C). Supernatants were harvested and analyzed for cytokine release by IFNgamma (D), IL-6 (E) and IL-8 (F) ELISA. Results are shown as mean+/-S.E.M. *, p<.05; **, p<0.005 (A, B and C, n = 3) (D, E and F, n = 5).
###end p 63
###begin title 64
Discussion
###end title 64
###begin p 65
###xml 373 377 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yoshimoto1">[58]</xref>
###xml 378 382 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Young3">[61]</xref>
###xml 574 578 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Barbulescu1">[62]</xref>
###xml 579 583 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yoshimoto3">[70]</xref>
###xml 1176 1180 1152 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Ortaldo1">[71]</xref>
Regulation of IFNgamma gene transcription involves the action of many different transcripition factors including STATs, AP-1, GATA-3, NFAT, T-bet, Eomesodermin, NFkappaB, NFAT, T-bet, YY-1, DREAM, ERM and SMADs. In most cases, multiple signals synergize for IFNgamma production via induction of different transcription factors that act in concert to induce gene expression [58]-[61]. The combination of IL-12 and IL-18 is the most well-known example of synergy between two cytokines for IFNgamma production in T cells, NK/NKT cells, B cells, macrophages and dendritic cells [62]-[70]. Synergy between IL-12 and IL-18 occurs not only at the transcription factor level via STAT4 and AP-1 activation, respectively, but also at the receptor level, with both cytokines upregulating cell surface expression of each other's receptors. Synergy for IFNgamma production has also been observed with the combination of receptor crosslinking and cytokine stimulation. As an example, the combination of LY49 activating receptor crosslinking and IL-12 or IL-18 synergistically enhance IFNgamma production in NK cells via the p38 MAP kinase and the ERK-dependent signal transduction pathways [71].
###end p 65
###begin p 66
###xml 206 209 198 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Raices1">[1]</xref>
###xml 211 215 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Cowland2">[24]</xref>
###xml 457 461 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Nakamura1">[72]</xref>
###xml 463 467 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Zhang2">[73]</xref>
###xml 576 580 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yoshimoto3">[70]</xref>
###xml 582 586 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Dinarello1">[74]</xref>
###xml 587 591 575 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Xu1">[77]</xref>
###xml 162 167 <span type="species:ncbi:9606">human</span>
In general, IL-12 and IL-18 require each other for IFNgamma gene expression. However, at high doses (50 ng/ml), IL-18 alone can induce IFNgamma production in the human acute myeloid leukemic KG-1 cell line [1], [24]. KG-1 cells have been widely used to study IL-18-mediated signaling events leading to IFNgamma expression. The responsiveness of KG-1 cells to IL-18 (in absence of IL-12) is partly due to constitutive expression of both chains of the IL-18R [72], [73], whereas primary NK and T cells require IL-12 stimulation for expression of the binding chain of the IL-18R [70], [74]-[77].
###end p 66
###begin p 67
###xml 260 264 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kojima1">[78]</xref>
###xml 452 456 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kojima1">[78]</xref>
###xml 457 461 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Torigoe1">[82]</xref>
###xml 596 600 556 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kojima1">[78]</xref>
NFkappaB has been shown to regulate the expression of many pro-inflammatory genes, IFNgamma being no exception. Two putative NFkappaB binding sites have been identified in the IFNgamma promoter region (kappaBB site and CD28RE) and one in the first intron (C3) [78]. The requirement for NFkappaB in IFNgamma gene expression appears to be contingent on the cell type and the specific stimulus. IL-18 signaling via the IL-18R leads to NFkappaB activation [78]-[82]. Moreover, stimulation of KG-1 cells with high doses (50 ng/ml) of IL-18 leads to IFNgamma production in an NFkappaB-dependent manner [78].
###end p 67
###begin p 68
###xml 176 179 165 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Raices1">[1]</xref>
###xml 749 753 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yoshimoto1">[58]</xref>
###xml 754 758 721 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Young3">[61]</xref>
We have previously described a novel synergistic role for the members of the IL-1 family, IL-1beta and IL-18, in combination with TNFalpha in IFNgamma production in KG-1 cells [1]. Importantly, at the dose of 10 ng/ml, the individual cytokines induced only minimal amounts of IFNgamma release. Given the striking similarities between the IL-1beta and IL-18 signaling pathways, we proposed that a common factor downstream of the IL-1R and IL-18R is responsible for the observed synergy between IL-1beta/IL-18 and TNFalpha. The latter is supported by the fact that induction of the IFNgamma promoter is generally mediated by multiple signals leading to activation of multiple transcription factors that synergistically induce IFNgamma gene expression [58]-[61].
###end p 68
###begin p 69
###xml 336 339 314 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Dunne1">[2]</xref>
###xml 340 343 318 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamamoto1">[5]</xref>
###xml 345 349 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamazaki1">[19]</xref>
###xml 350 354 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Cowland2">[24]</xref>
The novel member of the IkappaB family of NFkappaB regulators, IkappaBzeta, is known to be induced by IL-1R/TLR ligands. Moreover, even though the TNFR signaling pathway shares some similarities with the IL-1R/TLR pathway, such as the use of TRAF adaptor molecules, TNF signaling alone does not result in IkappaBzeta protein expression [2]-[5], [19]-[24]. Although IL-18 signals via a member of the IL-1R family, it has never been tested as an inducer of IkappaBzeta expression. We have shown for the first time that IL-18 stimulation also leads to IkappaBzeta protein expression in KG-1 cells.
###end p 69
###begin p 70
###xml 184 188 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamamoto2">[21]</xref>
###xml 190 194 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Cowland2">[24]</xref>
###xml 196 200 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kitamura1">[26]</xref>
###xml 202 206 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kayama1">[32]</xref>
###xml 208 212 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Matsuo1">[33]</xref>
###xml 214 218 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Trinh1">[35]</xref>
###xml 393 397 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-RodriguezGalan1">[66]</xref>
###xml 399 403 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Kojima1">[78]</xref>
###xml 405 409 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Sica1">[83]</xref>
IkappaBzeta has been shown to positively regulate NFkappaB-mediated transcription of secondary response genes such as IL-6 and NGAL, as a co-factor binding to the p50 NFkappaB subunit [21], [24], [26], [32], [33], [35]. Moreover, NFkappaB has been shown to play an important role as a positive regulator of IFNgamma gene expression in thymocytes, peripheral blood T lymphocytes and KG-1 cells [66], [78], [83]. Therefore, we hypothesized that IkappaBzeta may be the common factor downstream of the IL-1R and IL-18R pathways, which allows for synergy between IL-1 cytokines and TNFalpha for IFNgamma production in KG-1 cells.
###end p 70
###begin p 71
###xml 303 307 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamazaki2">[20]</xref>
###xml 1167 1170 1058 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1271 1275 1155 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamazaki2">[20]</xref>
Interestingly, we observed that TNFalpha enhanced IL-1beta/IL-18-mediated IkappaBzeta protein expression, even though by itself it had not effect on IkappaBzeta protein expression. However, TNFalpha, IL-1beta and LPS have all been shown to induce IkappaBzeta mRNA transcription in NIH3T3 and A549 cells [20]. Importantly, TNFalpha stimulation alone results in strong activation of the IkappaBzeta promoter without subsequent protein expression. Moreover, nuclear run-on analysis in NIH3T3 cells also indicates that TNFalpha is a stronger transcriptional activator of the IkappaBzeta gene, compared to IL-1beta or LPS. Furthermore, decay analysis of ectopically expressed IkappaBzeta mRNA upon actinomycin D treatment, indicates that degradation of IkappaBzeta mRNA is delayed by IL-1beta and LPS stimulation, but not by TNFalpha stimulation. Moreover, the N-terminal half, not the C-terminal half, of the IkappaBzeta ORF confers IL-1/LPS-mediated IkappaBzeta mRNA stabilization. Therefore, the specificity of IL-1/LPS stimulus for IkappaBzeta mRNA and protein induction is most likely at the post-transcriptional level and due to stabilization of IkappaBzeta mRNA. A cis-element in the N-terminal half of the IkappaBzeta gene appears to be crucial for this stabilization [20].
###end p 71
###begin p 72
###xml 124 127 117 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Cowland1">[9]</xref>
###xml 129 133 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Yamamoto2">[21]</xref>
###xml 135 139 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Sorensen2">[84]</xref>
###xml 141 145 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Flo1">[85]</xref>
###xml 235 239 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Cowland2">[24]</xref>
###xml 553 557 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Cowland2">[24]</xref>
###xml 800 804 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Ng1">[16]</xref>
###xml 805 809 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Elias1">[18]</xref>
###xml 1054 1057 989 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Cowland1">[9]</xref>
###xml 1059 1063 994 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Sorensen2">[84]</xref>
###xml 1079 1083 1014 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Cowland2">[24]</xref>
###xml 1210 1214 1135 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006776-Cowland2">[24]</xref>
###xml 1034 1039 <span type="species:ncbi:9606">human</span>
In support of the latter findings, the NGAL promoter has been shown to be specifically induced by IL-1beta, not by TNFalpha [9], [21], [84], [85]. NGAL promoter activity requires NFkappaB activation and an intact NFkappaB binding site [24]. Even though IL-1beta and TNFalpha, both induce NFkappaB nuclear translocation and recruitment to the NGAL promoter, only IL-1beta is able to induce NGAL expression. IkappaBzeta has been shown to be the co-factor which allows NFkappaB to mediate NGAL gene expression downstream of the IL-1R/TLR signaling pathway [24]. The latter was shown by IkappaBzeta over expression in A549 cells, which rescued TNFalpha-induced NGAL expression. The same may apply to expression of the IL-6 gene, which at least in the KG-1 cell line (data not shown) and other cell types [16]-[18], is specific to IL-1beta, not TNFalpha stimulation, and to other genes specifically induced downstream of the IL-1R/TLR pathway. As an additional example, hBD2 is also stimulated by IL-1beta, but not TNFalpha stimulation in human keratinocytes [9], [84] and A549 cells [24]. Moreover, siRNA experiments have shown that IkappaBzeta is critical for IL-1beta mediated hBD2 mRNA expression in A549 cells [24].
###end p 72
###begin p 73
###xml 925 931 833 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006776-g007">Fig. 7</xref>
Based on this information, we conclude that while IL-1beta and IL-18 may provide the signal(s) required for IkappaBzeta transcriptional activation, mRNA stabilization and subsequent IkappaBzeta protein expression, TNFalpha may enhance IL-1beta/IL-18-mediated IkappaBzeta expression by providing strong transcriptional activation of the IkappaBzeta gene. Moreover, TNFalpha stimulation of KG-1 cells provides robust binding of the p50 and p65 NFkappaB subunits to EMSA probes containing the NFkappaB binding sites present in the IFNgamma promoter and first intron (data not shown), compared to weaker binding provided by IL-1beta and IL-18. Therefore, robust NFkappaB activation provided by TNFalpha may also result in increased IFNgamma gene expression since IkappaBzeta regulates transcription as a co-factor for NFkappaB and KG-1 IFNgamma production in response to IL-1/TNFalpha combined stimulation is NFkappaB dependent (Fig. 7). Thus, the synergy between IL-1beta/IL-18 and TNFalpha may be due to their combined effects on IkappaBzeta expression, as well as on NFkappaB activation. Alternatively, other transcription factors induced by TNFalpha may synergize with IkappaBzeta/NFkappaB for IFNgamma gene expression. Receptor expression analysis indicated that TNFalpha-mediated upregulation of IL-1/IL-18R expression did not account for the synergy between these cytokines for IkappaBzeta production.
###end p 73
###begin p 74
In summary, we have shown a positive role for IkappaBzeta on IFNgamma production in response to IL-1beta, IL-18 and TNFalpha combined stimulation in KG-1 cells. This regulation is most likely dependent on the ability of IkappaBzeta to regulate NFkappaB mediated transcription of the IFNgamma gene. This finding represents a new addition to the complex and continuously growing literature on the regulation of IFNgamma expression.
###end p 74
###begin title 75
References
###end title 75
###begin article-title 76
A synergistic role for IL-1beta and TNFalpha in monocyte-derived IFNgamma inducing activity.
###end article-title 76
###begin article-title 77
The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense.
###end article-title 77
###begin article-title 78
Toll-like receptors in the induction of the innate immune response.
###end article-title 78
###begin article-title 79
Toll-like receptor signalling.
###end article-title 79
###begin article-title 80
TIR domain-containing adaptors define the specificity of TLR signaling.
###end article-title 80
###begin article-title 81
TNF-mediated inflammatory disease.
###end article-title 81
###begin article-title 82
NF-kappaB regulation in the immune system.
###end article-title 82
###begin article-title 83
Transcriptional and post-transcriptional control of gene expression in inflammation.
###end article-title 83
###begin article-title 84
###xml 62 67 <span type="species:ncbi:9606">human</span>
Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha.
###end article-title 84
###begin article-title 85
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation.
###end article-title 85
###begin article-title 86
By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide.
###end article-title 86
###begin article-title 87
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 128 133 <span type="species:ncbi:9606">human</span>
Lipopolysaccharide-induced IL-1 beta production by human uterine macrophages up-regulates uterine epithelial cell expression of human beta-defensin 2.
###end article-title 87
###begin article-title 88
###xml 55 60 <span type="species:ncbi:9606">human</span>
Differential regulation of beta-defensin expression in human skin by microbial stimuli.
###end article-title 88
###begin article-title 89
###xml 14 19 <span type="species:ncbi:9606">human</span>
Modulation of human beta-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production.
###end article-title 89
###begin article-title 90
###xml 113 118 <span type="species:ncbi:9606">human</span>
Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression.
###end article-title 90
###begin article-title 91
Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1.
###end article-title 91
###begin article-title 92
###xml 156 161 <span type="species:ncbi:9606">human</span>
IL-1 and tumor necrosis factor. Similarities and differences in stimulation of expression of alternative pathway of complement and IFN-beta 2/IL-6 genes in human fibroblasts.
###end article-title 92
###begin article-title 93
IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA.
###end article-title 93
###begin article-title 94
A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei.
###end article-title 94
###begin article-title 95
Stimulus-specific induction of a novel nuclear factor-kappaB regulator, IkappaB-zeta, via Toll/Interleukin-1 receptor is mediated by mRNA stabilization.
###end article-title 95
###begin article-title 96
Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta.
###end article-title 96
###begin article-title 97
Role of NF-kappaB in constitutive expression of MAIL in epidermal keratinocytes.
###end article-title 97
###begin article-title 98
Isolation of a novel interleukin-1-inducible nuclear protein bearing ankyrin-repeat motifs.
###end article-title 98
###begin article-title 99
IL-1beta-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IkappaB-zeta.
###end article-title 99
###begin article-title 100
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
Transcriptional regulation of the MAIL gene in LPS-stimulated RAW264 mouse macrophages.
###end article-title 100
###begin article-title 101
MAIL, a novel nuclear I kappa B protein that potentiates LPS-induced IL-6 production.
###end article-title 101
###begin article-title 102
Bacterial lipopolysaccharide induces mRNA expression of an IkappaB MAIL through toll-like receptor 4.
###end article-title 102
###begin article-title 103
Bacterial lipopolysaccharide-induced expression of the IkappaB protein MAIL in B-lymphocytes and macrophages.
###end article-title 103
###begin article-title 104
IkappaB-zeta, a new anti-inflammatory nuclear protein induced by lipopolysaccharide, is a negative regulator for nuclear factor-kappaB.
###end article-title 104
###begin article-title 105
IkappaB-zeta: an inducible regulator of nuclear factor-kappaB.
###end article-title 105
###begin article-title 106
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Genomic organization, chromosomal localization, and promoter analysis of the mouse Mail gene.
###end article-title 106
###begin article-title 107
Class-specific regulation of pro-inflammatory genes by MYD88 pathways and Ikappa Bzeta.
###end article-title 107
###begin article-title 108
Crucial roles of binding sites for NF-kappaB and C/EBPs in IkappaB-zeta-mediated transcriptional activation.
###end article-title 108
###begin article-title 109
Positive and negative regulation of nuclear factor-kappaB-mediated transcription by IkappaB-zeta, an inducible nuclear protein.
###end article-title 109
###begin article-title 110
The nuclear I kappaB protein I kappaB zeta specifically binds NF-kappaB p50 homodimers and forms a ternary complex on kappaB DNA.
###end article-title 110
###begin article-title 111
###xml 89 94 <span type="species:ncbi:9606">human</span>
Requirements for two proximal NF-kappaB binding sites and IkappaB-zeta in IL-17A-induced human beta-defensin 2 expression by conducting airway epithelium.
###end article-title 111
###begin article-title 112
###xml 38 43 <span type="species:ncbi:9606">human</span>
A novel member of the IkappaB family, human IkappaB-zeta, inhibits transactivation of p65 and its DNA binding.
###end article-title 112
###begin article-title 113
The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers.
###end article-title 113
###begin article-title 114
Diverse effects of BCL3 phosphorylation on its modulation of NF-kappaB p52 homodimer binding to DNA.
###end article-title 114
###begin article-title 115
Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo.
###end article-title 115
###begin article-title 116
The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition.
###end article-title 116
###begin article-title 117
The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.
###end article-title 117
###begin article-title 118
The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers.
###end article-title 118
###begin article-title 119
The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
###end article-title 119
###begin article-title 120
The proto-oncogene bcl-3 encodes an I kappa B protein.
###end article-title 120
###begin article-title 121
The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner.
###end article-title 121
###begin article-title 122
GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity.
###end article-title 122
###begin article-title 123
BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages.
###end article-title 123
###begin article-title 124
Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B.
###end article-title 124
###begin article-title 125
BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins.
###end article-title 125
###begin article-title 126
A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity.
###end article-title 126
###begin article-title 127
###xml 69 82 <span type="species:ncbi:10255">Variola virus</span>
Interleukin-18 and glycosaminoglycan binding by a protein encoded by Variola virus.
###end article-title 127
###begin article-title 128
###xml 160 164 <span type="species:ncbi:10090">mice</span>
IL-18-binding protein protects against lipopolysaccharide- induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice.
###end article-title 128
###begin article-title 129
###xml 74 79 <span type="species:ncbi:9606">human</span>
Identification of amino acid residues critical for biological activity in human interleukin-18.
###end article-title 129
###begin article-title 130
Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response.
###end article-title 130
###begin article-title 131
IL-18 receptor beta-induced changes in the presentation of IL-18 binding sites affect ligand binding and signal transduction.
###end article-title 131
###begin article-title 132
###xml 62 67 <span type="species:ncbi:9606">human</span>
IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins.
###end article-title 132
###begin article-title 133
IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils.
###end article-title 133
###begin article-title 134
Role of interferon-gamma in immune cell regulation.
###end article-title 134
###begin article-title 135
Regulation of interferon-gamma gene expression.
###end article-title 135
###begin article-title 136
IFN-gamma: recent advances in understanding regulation of expression, biological functions, and clinical applications.
###end article-title 136
###begin article-title 137
###xml 76 81 <span type="species:ncbi:9606">human</span>
IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes.
###end article-title 137
###begin article-title 138
Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-gamma production by dendritic cells.
###end article-title 138
###begin article-title 139
Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1.
###end article-title 139
###begin article-title 140
Regulation of interferon-gamma production by IL-12 and IL-18.
###end article-title 140
###begin article-title 141
Synergistic effect of IL-2, IL-12, and IL-18 on thymocyte apoptosis and Th1/Th2 cytokine expression.
###end article-title 141
###begin article-title 142
The production of IFN-gamma by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4.
###end article-title 142
###begin article-title 143
###xml 43 49 <span type="species:ncbi:10090">murine</span>
IL-12/IL-18-dependent IFN-gamma release by murine dendritic cells.
###end article-title 143
###begin article-title 144
Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells.
###end article-title 144
###begin article-title 145
IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.
###end article-title 145
###begin article-title 146
Regulation of ITAM-positive receptors: role of IL-12 and IL-18.
###end article-title 146
###begin article-title 147
###xml 33 38 <span type="species:ncbi:9606">human</span>
Expression and responsiveness of human interleukin-18 receptor (IL-18R) on hematopoietic cell lines.
###end article-title 147
###begin article-title 148
###xml 40 45 <span type="species:ncbi:9606">human</span>
Expression of IL-18 and its receptor in human leukemia cells.
###end article-title 148
###begin article-title 149
Interleukin-18.
###end article-title 149
###begin article-title 150
Interleukin-18.
###end article-title 150
###begin article-title 151
###xml 70 75 <span type="species:ncbi:9606">human</span>
IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells.
###end article-title 151
###begin article-title 152
Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells.
###end article-title 152
###begin article-title 153
An essential role for NF-kappa B in IL-18-induced IFN-gamma expression in KG-1 cells.
###end article-title 153
###begin article-title 154
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Interleukin-18 activates the IRAK-TRAF6 pathway in mouse EL-4 cells.
###end article-title 154
###begin article-title 155
###xml 38 44 <span type="species:ncbi:10090">murine</span>
Interleukin-18 activates NF-kappaB in murine T helper type 1 cells.
###end article-title 155
###begin article-title 156
IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB.
###end article-title 156
###begin article-title 157
###xml 41 46 <span type="species:ncbi:9606">human</span>
Purification and characterization of the human interleukin-18 receptor.
###end article-title 157
###begin article-title 158
Interaction of NF-kappaB and NFAT with the interferon-gamma promoter.
###end article-title 158
###begin article-title 159
###xml 71 76 <span type="species:ncbi:9606">human</span>
Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors.
###end article-title 159
###begin article-title 160
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron.
###end article-title 160
###begin p 161
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 161
###begin p 162
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was funded by NIH pre-doctoral fellowship (F31 AI 061828-02) to Raquel Raices and NIH grants - AHA fellowship-AHA725557 to AS and NIH grants-HL40871, HL076278 to MDW. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 162

